Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (SMMBF) AI Stock Analysis

0 Followers

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H

(Other OTC:SMMBF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue AccelerationThe sharp acceleration in revenue indicates improving commercial traction for the company’s medical robotics business. If sustained, stronger system adoption can expand the installed base and create additional recurring demand for instruments, consumables, and services over the next several quarters.

Negative Factors

Persistent UnprofitabilityThe company remains materially unprofitable, so revenue growth has not yet translated into sustainable earnings. A large net loss can limit internally funded investment, require continued external support, and make the durability of the business model dependent on achieving substantial operating leverage.

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (SMMBF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $2.80B
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -75.1
Beta (1Y): 3.72
Revenue Growth: 115.04%
EPS Growth: 63.16%
Country: US
Employees: 464
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H Business Overview & Revenue Model

Company Description

Shanghai MicroPort MedBot (Group) Co., Ltd. focuses on the comprehensive research, development, design, production, and distribution of surgical robotic systems, catering to markets in China and Europe. Their innovative product range features Toumai,...

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

SMMBF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:1789	77Outperform	HKD 5.30B	11.92	13.24%	2.48%	16.15%	31.89%
HK:2172	65Neutral	HKD 4.71B	21.36	10.38%	1.74%	3.83%	-27.04%
HK:2235	60Neutral	HKD 2.82B	28.07	4.08%	―	94.80%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
HK:2160	43Neutral	HKD 1.63B	-0.86	-6.69%	―	―	―
HK:0853	41Neutral	HKD 11.65B	31.23	6.07%	―	-3.62%	―

* Healthcare Sector Average

Performance Comparison

SMMBF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SMMBF	Shanghai MicroPort MedBot (Group) Co., Ltd. Class H	3.75	2.07	123.21%
HK:0853	MicroPort Scientific Corp	6.08	-5.41	-47.08%
HK:1789	AK Medical Holdings Ltd.	4.76	-1.24	-20.60%
HK:2160	MicroPort CardioFlow Medtech Corp.	1.28	-4.62	-78.31%
HK:2172	MicroPort NeuroTech Limited	8.05	-3.67	-31.30%
HK:2235	MicroTech Medical (Hangzhou) Co., Ltd. Class H	6.77	-0.13	-1.88%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H AI Stock Analysis